DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
OUABAIN
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
OUABAIN
×
Maximum Phase:
4
First Approval:
None
UNII:
5ACL011P69
Molecule Type:
Small molecule
Molecular Formula:
C29H44O12
Molecular Weight:
584.66
AlogP:
-1.51
PSA:
206.6
HBD:
8.0
HBA:
#RotB:
4.0
Source:
TULOBUTEROL
4
Small molecule
Approved
Unknown
Unknown
Lung Diseases, Obstructive
Beta-2 adrenergic receptor agonist
TULOBUTEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
591I9SU0F7
Molecule Type:
Small molecule
Molecular Formula:
C12H18ClNO
Molecular Weight:
227.74
AlogP:
2.76
PSA:
32.26
HBD:
2.0
HBA:
#RotB:
3.0
Source:
NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NOSCAPINE
4
Small molecule
Approved
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma; Cough
Unknown
NOSCAPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
8V32U4AOQU
Molecule Type:
Small molecule
Molecular Formula:
C22H23NO7
Molecular Weight:
413.43
AlogP:
2.88
PSA:
75.69
HBD:
0.0
HBA:
#RotB:
4.0
Source:
LACHESINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
LACHESINE
×
Maximum Phase:
4
First Approval:
None
UNII:
676774V4XX
Molecule Type:
Small molecule
Molecular Formula:
C20H26NO3+
Molecular Weight:
328.43
AlogP:
2.56
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TISOTUMAB VEDOTIN-TFTV
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TISOTUMAB VEDOTIN-TFTV
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
Lamivudine; Nevirapine; Zidovudine
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Lamivudine; Nevirapine; Zidovudine
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDIUM IN 111 CAPROMAB PENDETIDE
4
Antibody
Approved
Unknown
Unknown
Unknown
Diagnostic agent
INDIUM IN 111 CAPROMAB PENDETIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FARICIMAB-SVOA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FARICIMAB-SVOA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NADROPARIN
4
Oligosaccharide
Approved
Unknown
Unknown
Unknown
Unknown
NADROPARIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; DEXTROSE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; DEXTROSE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INTRINSIC FACTOR
4
Unknown
Approved
Unknown
Unknown
Anemia
Unknown
INTRINSIC FACTOR
×
Maximum Phase:
4
First Approval:
None
UNII:
70BT6OQT2Q
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XENON XE 133
4
Small molecule
Approved
Unknown
Unknown
Unknown
Diagnostic agent
XENON XE 133
×
Maximum Phase:
4
First Approval:
None
UNII:
X3P9A5HNYF
Molecule Type:
Small molecule
Molecular Formula:
Xe
Molecular Weight:
132.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
HUPERZINE A
4
Small molecule
Approved
Unknown
Unknown
Cocaine-Related Disorders; Substance-Related Disorders; Alzheimer Disease; Brain Injuries
Unknown
HUPERZINE A
×
Maximum Phase:
4
First Approval:
None
UNII:
0111871I23
Molecule Type:
Small molecule
Molecular Formula:
C15H18N2O
Molecular Weight:
242.32
AlogP:
2.0
PSA:
58.88
HBD:
2.0
HBA:
#RotB:
0.0
Source:
ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HEMOPORFIN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
HEMOPORFIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORQUINALDOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CHLORQUINALDOL
×
Maximum Phase:
4
First Approval:
None
UNII:
D6VHC87LLS
Molecule Type:
Small molecule
Molecular Formula:
C10H7Cl2NO
Molecular Weight:
228.08
AlogP:
3.56
PSA:
33.12
HBD:
1.0
HBA:
#RotB:
0.0
Source:
BENPERIDOL
4
Small molecule
Approved
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Schizophrenia; Psychotic Disorders
Dopamine D2 receptor antagonist
BENPERIDOL
×
Maximum Phase:
4
First Approval:
None
UNII:
97O6X78C53
Molecule Type:
Small molecule
Molecular Formula:
C22H24FN3O2
Molecular Weight:
381.45
AlogP:
4.18
PSA:
58.36
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TRASTUZUMAB-PKRB
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TRASTUZUMAB-PKRB
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; LEVONORGESTREL
4
Combination
Approved
OTHER; PREGNANCY AND GYNECOLOGY
ORAL; ORAL-21; ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; LEVONORGESTREL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODOXAMATE MEGLUMINE
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IODOXAMATE MEGLUMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
CIX5G6J9R1
Molecule Type:
Small molecule
Molecular Formula:
C40H60I6N4O20
Molecular Weight:
1678.35
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
INSULIN HUMAN
4
Protein
Approved
Unknown
INTRAVENOUS; SUBCUTANEOUS
Unknown
Unknown
INSULIN HUMAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLYCOLIC ACID
4
Small molecule
Approved
Unknown
Unknown
Melanosis; Acne Vulgaris; Herpes Labialis
Unknown
GLYCOLIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
0WT12SX38S
Molecule Type:
Small molecule
Molecular Formula:
C2H4O3
Molecular Weight:
76.05
AlogP:
-0.94
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
1.0
Source:
BUTAMBEN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Transient receptor potential cation channel subfamily A member 1 inhibitor
BUTAMBEN
×
Maximum Phase:
4
First Approval:
None
UNII:
EFW857872Q
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO2
Molecular Weight:
193.25
AlogP:
2.23
PSA:
52.32
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PROCAINE HYDROCHLORIDE; TETRACYCLINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
PROCAINE HYDROCHLORIDE; TETRACYCLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLDINE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
POLDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
8R92106W2F
Molecule Type:
Small molecule
Molecular Formula:
C21H26NO3+
Molecular Weight:
340.44
AlogP:
2.7
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SARPOGRELATE
4
Small molecule
Approved
Unknown
Unknown
Cerebral Infarction; Peripheral Arterial Disease
Serotonin 2a (5-HT2a) receptor antagonist
SARPOGRELATE
×
Maximum Phase:
4
First Approval:
None
UNII:
19P708E787
Molecule Type:
Small molecule
Molecular Formula:
C24H31NO6
Molecular Weight:
429.51
AlogP:
3.2
PSA:
85.3
HBD:
1.0
HBA:
#RotB:
13.0
Source:
NITROGEN, NF
4
Unknown
Approved
Unknown
INHALATION
Unknown
Unknown
NITROGEN, NF
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEUPROLIDE ACETATE; NORETHINDRONE ACETATE
4
Combination
Approved
OTHER
INTRAMUSCULAR; ORAL
Unknown
Unknown
LEUPROLIDE ACETATE; NORETHINDRONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ERGONOVINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ERGONOVINE
×
Maximum Phase:
4
First Approval:
None
UNII:
WH41D8433D
Molecule Type:
Small molecule
Molecular Formula:
C19H23N3O2
Molecular Weight:
325.41
AlogP:
1.53
PSA:
68.36
HBD:
3.0
HBA:
#RotB:
3.0
Source:
TECHNETIUM TC-99M MERTIATIDE KIT
4
Protein
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M MERTIATIDE KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALISKIREN HEMIFUMARATE
4
Small molecule
Approved
CARDIOVASCULAR; OTHER
ORAL
Unknown
Unknown
ALISKIREN HEMIFUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISOXICAM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Cyclooxygenase inhibitor
ISOXICAM
×
Maximum Phase:
4
First Approval:
None
UNII:
8XU734C4NG
Molecule Type:
Small molecule
Molecular Formula:
C14H13N3O5S
Molecular Weight:
335.34
AlogP:
1.48
PSA:
112.74
HBD:
2.0
HBA:
#RotB:
2.0
Source:
HYDROCODONE
4
Small molecule
Approved
Unknown
Unknown
Ankle Fractures; Eye Diseases; Rotator Cuff Injuries; Wounds and Injuries; Chronic Pain; Low Back Pain; Nausea; Osteoarthritis; Pain; Vomiting; Cough
Unknown
HYDROCODONE
×
Maximum Phase:
4
First Approval:
None
UNII:
6YKS4Y3WQ7
Molecule Type:
Small molecule
Molecular Formula:
C18H21NO3
Molecular Weight:
299.37
AlogP:
1.93
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
1.0
Source:
1
2
…
292
293
294
295
296
297
298
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA